Analysis method of compound and related impurities thereof
Through high-performance liquid chromatography analysis method, the problem of compound LF0231 and its impurity analysis was solved, and the separation and quantitative analysis of compound LF0231, with fermentine acid, methyl 3-methoxy-4-aminocinnamic acid and main degradation products were achieved. Meets the specificity and sensitivity requirements of the analysis.
Patent Information
- Application Number
- CN202310643334.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-01
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art lacks effective methods to rapidly analyze compound LF0231 and its related impurities generated under a variety of conditions, which affects its research and utilization.
High performance liquid chromatography analysis method, including the use of a capped C18 chromatography column, the mobile phase is 0.05%-0.15% v/v TFA aqueous solution-0.05%-0.15% v/v TFA acetonitrile solution, column temperature is 30-40℃, flow rate 0.8-1.2ml/min, the detection wavelength was 315-330nm. The separation of compound LF0231 from retinoic acid, methyl 3-methoxy-4-aminocinate and main degradation products was achieved through this method, and qualitative quantitative analysis was carried out.
This method meets the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and can quickly and accurately analyze LF0231 and its impurities, and is suitable for its qualitative and quantitative analysis.
Smart Images

Figure QLYQS_1 
Figure QLYQS_2 
Figure BDA0004262383750000011
Abstract
Description
Technical Field
[0001] The invention belongs to the field of chemical analysis, and in particular relates to an analysis method for a compound and related impurities thereof. Background Art
[0002] Compound LF0231 is a new vitamin A active compound. Studies have shown that it has good anti-wrinkle and antibacterial effects. A synthetic route of LF0231 is as follows:
[0003]
[0004] In order to further study and utilize LF0231, firstly, its product needs to be analyzed and tested. Therefore, the art is in urgent need of providing a rapid analysis method for related impurities in LF0231 and its samples. Summary of the invention
[0005] The object of the present invention is to provide an analytical method capable of detecting compound LF0231 and related impurities produced under various conditions.
[0006] The present invention provides a high performance liquid chromatography analysis method for LF0231 and related impurities thereof, the method comprising the steps of:
[0007]
[0008] (i) providing a sample;
[0009] (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data;
[0010] Wherein, the detection conditions of the chromatogram include:
[0011] The chromatographic column was an end-capped C18 column, 4.6 × 250 mm, 5 μm;
[0012] Mobile phase: 0.05%-0.15% v / v TFA aqueous solution-0.05%-0.15% v / v TFA acetonitrile solution: 8:2, by volume ratio;
[0013] Elution mode: isocratic elution;
[0014] Column temperature: 30-40°C;
[0015] Flow rate: 0.8-1.2 ml / min; and
[0016] Detection wavelength: 315-330 nm. In another preferred embodiment, the mobile phase is 0.1% v / v TFA aqueous solution-0.1% v / v TFA acetonitrile solution v / v: 8:2, calculated by volume ratio.
[0017] In another preferred embodiment, the elution time of a sample is ≥45 min, preferably 45-80 min, and more preferably 60 min.
[0018] In another preferred embodiment, the end-capping refers to removing the residual silanol groups on the surface of the column packing.
[0019] In another preferred example, the sample includes LF0231.
[0020] In another preferred embodiment, the sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, and RRT0.95.
[0021] In another preferred embodiment, the sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, RRT0.26, RRT0.46, RRT0.86, RRT0.90, RRT0.95, RRT1.06, wherein RRT represents the relative retention time with LF0231.
[0022] In another preferred embodiment, the sample includes LF0231, and the sample is treated with one or more selected from the following groups: acid destruction (such as pH <3 or pH <1), alkali destruction (such as pH >11 or pH >14), oxidation, light destruction, high temperature destruction (such as storage at temperature >80°C for 1 day, preferably temperature >100°C), and high humidity destruction.
[0023] In another preferred embodiment, the chromatographic column is kromasil 100-5-C18, 4.6×250 mm, 5 μm.
[0024] In another preferred embodiment, the dilution solution of the sample is acetonitrile.
[0025] In another preferred embodiment, the injection volume of the sample is 10 μl to 25 μl.
[0026] In another preferred embodiment, the column temperature is 35°C.
[0027] In another preferred embodiment, the flow rate is 1.0 mL / min.
[0028] In another preferred embodiment, the detection wavelength is 317-327 nm, preferably 322 nm.
[0029] In another preferred embodiment, the method further comprises the step of: using a standard sample to perform qualitative analysis on the sample by retention time.
[0030] In another preferred embodiment, the method further comprises the step of: using a standard sample to establish an external standard curve by the method, so as to quantitatively analyze the concentration of the analyte in the sample to be tested.
[0031] In another preferred embodiment, LF0231 in the sample is Response obtained.
[0032] In another preferred embodiment, the LF0231 in the sample is prepared by the following method:
[0033]
[0034] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 It is the UV absorption spectrum of retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester and compound LF0231.
[0036] Figure 2 This is a chromatogram of the blank solution of Example 2.
[0037] Figure 3 This is a chromatogram of the separation solution of Example 2.
[0038] Figure 4 This is a chromatogram of the undamaged sample solution of Example 3.
[0039] Figure 5 This is a chromatogram of the acid-destroyed sample solution of Example 3.
[0040] Figure 6 This is a chromatogram of the alkali-damaged sample solution of Example 3.
[0041] Figure 7 This is a chromatogram of the oxidative damage sample solution of Example 3.
[0042] Figure 8 This is a chromatogram of the high temperature destroyed sample solution of Example 3.
[0043] Fig. 9 This is a chromatogram of the high humidity damage sample solution of Example 3.
[0044] Fig.10 This is a chromatogram of the light-damaged sample solution of Example 3. DETAILED DESCRIPTION
[0045] The inventors have conducted extensive and in-depth research, and through a large number of screenings and tests, provided a high performance liquid chromatography analysis method for LF0231 and its related impurities. The method of the invention can separate the compound LF0231 from retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester and the main degradation products, and can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and can be used for the rapid qualitative and quantitative analysis of LF0231 and its related impurities. The invention was completed on this basis.
[0046] the term
[0047] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
[0048] As used herein, when used in reference to a specific recited numerical value, the term "about" means that the value may vary by no more than 1% from the recited value. For example, as used herein, the expression "about 100" includes all values between 99 and 101 (e.g., 99.1, 99.2, 99.3, 99.4, etc.).
[0049] As used herein, the term "comprising" or "including (comprising)" may be open, semi-closed and closed. In other words, the term also includes "consisting essentially of" or "consisting of".
[0050] As used herein, the term "room temperature" or "normal temperature" refers to a temperature of 4-40°C, preferably, 25±5°C.
[0051] HPLC Analysis Method for LF0231 and Its Related Impurities
[0052] The present invention provides a high performance liquid chromatography analysis method for LF0231 and related impurities thereof, the method comprising the steps of:
[0053]
[0054] (i) providing a sample;
[0055] (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data;
[0056] Wherein, the detection conditions of the chromatogram include:
[0057] The chromatographic column was an end-capped C18 column, 4.6 × 250 mm, 5 μm;
[0058] Mobile phase: 0.05%-0.15% v / v TFA aqueous solution-0.05%-0.15% v / v TFA acetonitrile solution: 8:2, by volume ratio;
[0059] Elution mode: isocratic elution;
[0060] Column temperature: 30-40°C;
[0061] Flow rate: 0.8-1.2 ml / min; and
[0062] Detection wavelength: 315-330 nm. Preferably, the mobile phase is 0.1% v / v TFA aqueous solution-0.1% v / v TFA acetonitrile solution v / v: 8:2, by volume ratio.
[0063] In the present invention, the "end-capping" of the chromatographic column refers to the removal of the (free, unreacted) silanol groups remaining on the surface of the column packing, such as the silanol groups remaining after the reaction of silica gel with a macromolecular silanization agent (e.g., octadecyltrichlorosilane). Generally, a small molecule silanization agent (e.g., trimethylchlorosilane or dichlorodimethylsilane) can be used to bond the residual silanol groups, thereby end-capping the chromatographic column.
[0064] In another preferred example, the sample includes LF0231.
[0065] In another preferred embodiment, the sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, and RRT0.95.
[0066] In another preferred embodiment, the sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, RRT0.26, RRT0.46, RRT0.86, RRT0.90, RRT0.95, RRT1.06, wherein RRT represents the relative retention time with LF0231.
[0067] In another preferred embodiment, the sample includes LF0231, and the sample is treated with one or more selected from the following groups: acid destruction (such as pH <3 or pH <1), alkali destruction (such as pH >11 or pH >14), oxidation, light destruction, high temperature destruction (such as storage at temperature >80°C for 1 day, preferably temperature >100°C), and high humidity destruction.
[0068] In another preferred embodiment, the chromatographic column is kromasil 100-5-C18, 4.6×250 mm, 5 μm.
[0069] In another preferred embodiment, the dilution solution of the sample is acetonitrile.
[0070] In another preferred embodiment, the injection volume of the sample is 10 μl to 25 μl.
[0071] In another preferred embodiment, the column temperature is 35°C.
[0072] In another preferred embodiment, the flow rate is 1.0 mL / min.
[0073] In another preferred embodiment, the detection wavelength is 317-327 nm, preferably 322 nm.
[0074] In another preferred embodiment, the method further comprises the step of: using a standard sample to perform qualitative analysis on the sample by retention time.
[0075] In another preferred embodiment, the method further comprises the step of: using a standard sample to establish an external standard curve by the method, so as to quantitatively analyze the concentration of the analyte in the sample to be tested.
[0076] In another preferred embodiment, LF0231 in the sample is Response obtained.
[0077] In another preferred embodiment, the LF0231 in the sample is prepared by the following method:
[0078]
[0079] The main advantages of the present invention include:
[0080] The present invention provides a high performance liquid chromatography analysis method for LF0231 and related impurities, by which the compound LF0231 can be separated from retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester (i.e., compound 3) and multiple main degradation products. The method of the present invention can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and can be used for rapid qualitative and quantitative analysis of LF0231 and related impurities.
[0081] The present invention will be further described below in conjunction with specific implementation. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.
[0082] Example 1
[0083] Choice of initial conditions:
[0084] The initial chromatographic conditions were: chromatographic column: kromasil 100-5-C18, 4.6×250 mm, 5 μm; mobile phase: 0.1% TFA aqueous solution-0.1% TFA acetonitrile solution (9:1); flow rate: 1.0 ml / min, column temperature: 35°C, injection volume: 10 μl, detector: PDA.
[0085] Retinoic acid and 3-methoxy-4-aminocinnamic acid methyl ester are organic acids and organic bases respectively. Adding 0.1% trifluoroacetic acid (TFA) to the system improves the peak shapes of the two. Compound LF0231, retinoic acid, and 3-methoxy-4-aminocinnamic acid methyl ester are all weakly polar compounds, and 0.1% TFA aqueous solution-0.1% TFA acetonitrile solution (9:1) was used for isocratic elution. 3-methoxy-4-aminocinnamic acid methyl ester contains basic groups, and a capped chromatographic column kromasil 100-5-C18, 4.6×250mm, 5μm was used to reduce tailing.
[0086] 2. According to the initial conditions, 0.1% TFA aqueous solution-0.1% TFA acetonitrile solution (9:1) was used for isocratic elution. The separation degree between retinoic acid and compound LF0231 was 2.0, and the elution times of the two compounds were close.
[0087] 3. Reduce the proportion of organic phase, 0.1% TFA aqueous solution and 0.1% TFA acetonitrile solution were eluted isocratically at (8:1), the separation degree of retinoic acid and compound LF0231 was 6.7, and the separation was significantly improved.
[0088] 4. Selection of PDA detection wavelength:
[0089] like Figure 1 At 322 nm, retinoic acid, methyl 3-methoxy-4-aminocinnamate and compound LF0231 all have good absorption, so 322 nm was selected as the detection wavelength.
[0090] Method investigation:
[0091] 1. Example 2-8 The method was investigated according to the following chromatographic conditions:
[0092] Chromatographic column model: kromasil 100-5-C18 (4.6×250mm, 5μm);
[0093] Mobile phase: 0.1% TFA aqueous solution-0.1% TFA acetonitrile solution (8:2);
[0094] Column temperature: 35°C;
[0095] Flow rate: 1.0 ml / min;
[0096] Detector: PDA;
[0097] Wavelength: 322nm;
[0098] Injection volume: 10 μL;
[0099] Elution mode: isocratic elution;
[0100] Elution time: 60min.
[0101] 2. Solution preparation:
[0102] Blank solution: acetonitrile;
[0103] Separation solution: Take an appropriate amount of retinoic acid and dissolve it in methanol to form a 1 mg / ml retinoic acid stock solution; take an appropriate amount of 3-methoxy-4-aminocinnamic acid methyl ester and dissolve it in acetonitrile to form a 1 mg / ml 3-methoxy-4-aminocinnamic acid methyl ester stock solution; take about 50 mg of LF0231 test sample, accurately weigh it, and place it in a 50 ml volumetric flask. At the same time, measure 0.5 ml of retinoic acid stock solution and 0.5 ml of 3-methoxy-4-aminocinnamic acid methyl ester stock solution into the volumetric flask, dissolve them in acetonitrile and dilute to the scale.
[0104] Test solution: Take about 50 mg of 3-methoxy-4-aminocinnamic acid methyl ester, accurately weigh it, place it in a 50 ml volumetric flask, dissolve it with acetonitrile and dilute it to the scale.
[0105] Impurity calculation method: The impurity content is calculated using the area normalization method with a correction factor. The correction factor for retinoic acid is 1.2, and other unknown impurities are calculated as 1.0.
[0106] Example 2. System suitability study
[0107] Take blank solution (acetonitrile) and separation solution for injection, the separation degree between each component should be no less than 1.5. Results: The blank solution has no interference, and in the separation solution, the minimum separation degree of compound LF0231 and retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester and adjacent impurities is 1.6, which meets the requirements ( Figure 2-3 ).
[0108] Example 3. Specificity investigation through forced degradation experiment
[0109] Control undegraded sample solution: Take about 50 mg of LF0321 sample, accurately weigh it, place it in a 50 ml volumetric flask, dissolve it in acetonitrile and dilute it to the scale.
[0110] Acid degradation solution: Take about 50 mg of LF0321 sample, weigh accurately, put it in a 50 ml volumetric flask, add 2 ml of acetonitrile and 1 ml of 1 mol / l hydrochloric acid, mix well. After leaving at room temperature for 30 minutes, add 1 ml of 1 mol / L NaOH to neutralize, and dilute to the mark with acetonitrile.
[0111] Alkali-destroyed sample solution: Take about 50 mg of the sample, weigh accurately, put it in a 50 ml volumetric flask, add 2 ml acetonitrile and 1 ml 1 mol / L NaOH, mix well. After leaving it at room temperature for 2 hours, add 1 ml 1 mol / L HCl to neutralize it, and dilute it to the mark with acetonitrile.
[0112] Oxidative damage sample solution: Take about 50 mg of the sample, weigh accurately, put it in a 50 ml volumetric flask, add 1 ml of acetonitrile and 1 ml of 3% hydrogen peroxide, mix well, leave it at room temperature for 30 minutes, and then dilute it to the mark with acetonitrile.
[0113] Light-damaged sample solution: Take an appropriate amount of the sample, spread it flat in a weighing bottle, and leave it open at 4500±500lx for 5 days before taking it out. Take about 50mg of the light-damaged sample, weigh it accurately, put it in a 50ml volumetric bottle, dissolve it with acetonitrile and dilute it to the mark.
[0114] High temperature damaged sample solution: Take an appropriate amount of the sample, spread it flat in a weighing bottle, leave it open at 105℃ for 1 day and then take it out. Take about 50mg of the sample after high temperature damage, weigh it accurately, put it in a 50ml volumetric bottle, dissolve it with acetonitrile and dilute it to the scale.
[0115] High humidity damaged sample solution: Take an appropriate amount of the sample, spread it flat in a weighing bottle, and place it in a saturated potassium nitrate solution for 5 days before taking it out. Take about 50 mg of the sample after high humidity damage, accurately weigh it, place it in a 100 ml volumetric bottle, dissolve it with acetonitrile and dilute it to the scale.
[0116] The results are shown in Table 1:
[0117] Table 1
[0118]
[0119]
[0120] From the above table 1 and Figure 3-10 It can be seen that the degradation impurities of compound LF0231 are mainly retinoic acid, methyl 3-methoxy-4-aminocinnamate, RRT0.86, and RRT0.95. This method can simultaneously separate LF0321 from the above impurities. The peak purity of the main peak under each degradation condition is analyzed by PDA. The spectral purity of compound LF0231 meets the requirements, and the recovery rate of material balance is between 99% and 100%. This shows that this method meets the requirements of specificity and material balance.
[0121] Example 4. Sensitivity study
[0122] Dilute the mixed standard solution of LF0231, 3-methoxy-4-aminocinnamic acid methyl ester and retinoic acid step by step, confirm the detection limit and quantification limit of each component, and take the quantification limit solution for 6 consecutive injections. The signal-to-noise ratio of the detection limit should be no less than 3, and the signal-to-noise ratio of the quantification limit should be no less than 10.
[0123] The results are shown in Table 2:
[0124] Table 2
[0125]
[0126] Example 5. Linear
[0127] A series of mixed solutions of LF0231, methyl 3-methoxy-4-aminocinnamate and retinoic acid were prepared and injected respectively. Linear curves were drawn between the peak areas at different concentrations and the corresponding concentrations. The linear equations of each component were obtained, and the correction factors of retinoic acid A and methyl 3-methoxy-4-aminocinnamate were calculated.
[0128] The results are shown in Table 3:
[0129] Table 3
[0130]
[0131] Retinoic acid, methyl 3-methoxy-4-aminocinnamate and LF0231 all show a good linear relationship, so the impurity content of compound LF0231 can be calculated by the area normalization method with correction factor added. The correction factor of methyl 3-methoxy-4-aminocinnamate is between 0.9 and 1.1 and does not need to be included in the calculation. The correction factor of retinoic acid needs to be 1.2.
[0132] Example 6. Repeatability study
[0133] Six samples of 2 μg / ml retinoic acid and methyl 3-methoxy-4-aminocinnamate spiked solution were prepared and injected six times to investigate the RSD of the impurity detection amount in the test sample. The content of each impurity was calculated by the area normalization method with the correction factor added.
[0134] The results of the repeatability study (only for impurities greater than 0.05%) are shown in Table 4:
[0135] Table 4
[0136]
[0137]
[0138] Results: The RSD of the impurity detection amount was between 2% and 4%, indicating that the method could meet the repeatability requirements.
[0139] Example 7. Accuracy Study
[0140] Three concentration levels of retinoic acid and 3-methoxy-4-aminocinnamic acid methyl ester were added to the test solution, and the spiked recoveries of retinoic acid and 3-methoxy-4-aminocinnamic acid methyl ester were investigated.
[0141] Table 5
[0142]
[0143] The results are shown in Table 5 above. The spiked recoveries of retinoic acid and methyl 3-methoxy-4-aminocinnamate were between 96% and 102%.
[0144] Example 8. Durability Study
[0145] The chromatographic parameters including column temperature (35±5°C), flow rate (1.0±0.2ml / min), wavelength (322±5nm), and TFA content (0.05% and 0.15%) were adjusted, and the spiked sample solution was injected under the repeatability test conditions.
[0146] Table 6
[0147]
[0148]
[0149] The results are shown in Table 6 above. The method can meet the detection requirements for various impurities within the parameter range of column temperature 30±5°C, flow rate 1.0±0.2ml / min, wavelength 322±5nm, and percentage of trifluoroacetic acid 0.05-0.15%.
[0150] In summary, the method of the present invention can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and can be used for rapid qualitative and quantitative analysis of LF0231 and its related impurities.
[0151] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.
Claims
1. A high performance liquid chromatography analysis method for LF0231 and its related impurities, characterized in that: The method comprises the steps of: (i) providing a sample; (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data; Wherein, the detection conditions of the chromatogram include: The chromatographic column was an end-capped C18 column, 4.6 × 250 mm, 5 μm; Mobile phase: 0.05%-0.15% v / v TFA aqueous solution-0.05%-0.15% v / v TFA acetonitrile solution: 8:2, by volume ratio; Elution mode: isocratic elution; Column temperature: 30-40°C; Flow rate: 0.8-1.2 ml / min; and Detection wavelength: 315-330nm.
2. The method according to claim 1, characterized in that The mobile phase is 0.1% v / v TFA aqueous solution-0.1% v / v TFA acetonitrile solution v / v: 8:2, calculated by volume ratio.
3. The method according to claim 1, characterized in that The sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, and RRT0.
95.
4. The method according to claim 1, characterized in that The sample includes one or more substances selected from the following group: compound LF0231, retinoic acid, 3-methoxy-4-aminocinnamic acid methyl ester, RRT0.26, RRT0.46, RRT0.86, RRT0.90, RRT0.95, RRT1.06, wherein RRT represents the relative retention time with LF0231.
5. The method according to claim 1, characterized in that The sample includes LF0231, and the sample is treated with one or more selected from the following groups: acid damage (such as pH <3 or pH <1), alkali damage (such as pH>11 or pH>14), oxidation, light damage, high temperature damage (such as storage at temperature>80°C for 1 day, preferably temperature>100°C), and high humidity damage.
6. The method according to claim 1, characterized in that The chromatographic column is kromasil100-5-C18, 4.6×250 mm, 5 μm.
7. The method according to claim 1, characterized in that The method comprises one or more of the following features: The diluting solution of the sample is acetonitrile; The injection volume of the sample is 10 μl to 25 μl; The column temperature is 35°C; The flow rate is 1.0 mL / min; and / or The detection wavelength is 317-327 nm, preferably 322 nm.
8. The method according to claim 1, characterized in that The method further comprises the step of using a standard sample to perform qualitative analysis on the sample by retention time.
9. The method according to claim 1, characterized in that The method further comprises the step of: using a standard sample to establish an external standard curve through the method, thereby quantitatively analyzing the concentration of the analyte in the sample to be tested.
10. The method according to claim 1, characterized in that The LF0231 in the sample was prepared by the following method:
